While childhood obesity is indeed a risk factor for health disorders both in youth and in adulthood, some medical experts are concerned that putting children that young on drugs as powerful and relatively new as GLP-1s could cause more harm than good
Chiang concluded that longer-term studies are needed to clarify potential risks or benefits associated with GLP-1 receptor agonists, adding that his team will continue to monitor emerging data from both RCTs and observational studies.
Discovery of new glucose uptake inhibitors as potential anticancer agents by non-radioactive cell-based assays
[DOI] [PubMed] [Google Scholar] 44.Shin S., Wakabayashi J., Yates M.S., Wakabayashi N., Dolan P.M., Aja S., Liby K.T., Sporn M.B., Yamamoto M., Kensler T.W